Terug
42
35
64
Dagbereik
€ 450,07
€ 466,51
52-Weeksbereik
€ 250,05
€ 628,92
Volume
197.708
50D / 200D Gem.
€ 512,21
/
€ 488,76
Vorige Slotkoers
€ 456,93
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 29,0 | 0,3 |
| P/B | 28,5 | 2,9 |
| ROE % | 70,2 | 3,7 |
| Net Margin % | 17,8 | 3,8 |
| Rev Growth 5Y % | 22,0 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 534,17
+15.9%
Low: € 460,00
High: € 582,00
Forward K/W
26,7
Forward WPA
€ 17,13
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,8 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 25,05
€ 23,49 – € 26,26
|
3,9 B | 4 |
| FY2029 |
€ 24,00
€ 22,50 – € 25,16
|
3,6 B | 4 |
| FY2028 |
€ 21,70
€ 20,28 – € 23,41
|
3,3 B | 10 |
Belangrijkste Punten
Revenue grew 21,99% annually over 5 years — strong growth
ROE of 70,23% indicates high profitability
Net margin of 17,83% shows strong profitability
Generating 681,87M in free cash flow
Cash machine — converts 151,15% of earnings into free cash flow
Capital efficient — spends only 1,24% of revenue on capex
Groei
Revenue Growth (5Y)
21,99%
Revenue (1Y)19,97%
Earnings (1Y)11,56%
FCF Growth (3Y)31,10%
Kwaliteit
Return on Equity
70,23%
ROIC56,54%
Net Margin17,83%
Op. Margin21,14%
Veiligheid
Debt / Equity
0,55
Current Ratio0,74
Interest Coverage0,00
Waardering
P/E Ratio
28,99
P/B Ratio28,48
EV/EBITDA23,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,97% | Revenue Growth (3Y) | 15,83% |
| Earnings Growth (1Y) | 11,56% | Earnings Growth (3Y) | 26,30% |
| Revenue Growth (5Y) | 21,99% | Earnings Growth (5Y) | 25,50% |
| Profitability | |||
| Revenue (TTM) | 2,53B | Net Income (TTM) | 451,12M |
| ROE | 70,23% | ROA | 22,84% |
| Gross Margin | 30,06% | Operating Margin | 21,14% |
| Net Margin | 17,83% | Free Cash Flow (TTM) | 681,87M |
| ROIC | 56,54% | FCF Growth (3Y) | 31,10% |
| Safety | |||
| Debt / Equity | 0,55 | Current Ratio | 0,74 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 28,99 | P/B Ratio | 28,48 |
| P/S Ratio | 5,17 | PEG Ratio | 1,82 |
| EV/EBITDA | 23,98 | Dividend Yield | 0,00% |
| Market Cap | 13,08B | Enterprise Value | 12,83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,53B | 2,11B | 1,89B | 1,46B | 1,14B |
| Net Income | 451,12M | 404,39M | 282,81M | 245,37M | 181,85M |
| EPS (Diluted) | 15,28 | 12,63 | 8,88 | 7,28 | 4,81 |
| Gross Profit | 760,62M | 656,31M | 524,51M | 432,44M | 328,16M |
| Operating Income | 534,94M | 446,87M | 336,83M | 278,70M | 198,62M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,98B | 2,10B | 1,66B | 1,35B | 1,66B |
| Total Liabilities | 1,52B | 1,28B | 1,10B | 966,11M | 707,01M |
| Shareholders' Equity | 459,07M | 825,55M | 558,95M | 386,39M | 952,93M |
| Total Debt | 250,50M | 149,52M | 142,12M | 188,87M | 130,97M |
| Cash & Equivalents | 497,05M | 669,44M | 245,45M | 28,27M | 461,30M |
| Current Assets | 989,62M | 1,03B | 593,83M | 333,96M | 690,91M |
| Current Liabilities | 1,34B | 1,10B | 925,13M | 803,47M | 557,22M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#586 of 1052
Custom
Capital Light Compounder
#136 of 218
Custom
Balanced Risk
#12 of 151
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Balanced Risk
Mar 24, 2026